GUANGDONG HYBRIBIO BIOTECH CO.,LTD. Guangdong Hybribio Biotech Co.,Ltd. Share Price
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.28 CNY | +1.29% |
|
+2.78% | -32.76% |
| 26/04 | Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 24/04 | Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
| Sales 2024 * | 1.58B 218M 18.16B | Sales 2025 * | 2.07B 287M 23.92B | Capitalization | 4.01B 555M 46.26B |
|---|---|---|---|---|---|
| Net income 2024 * | 284M 39.27M 3.28B | Net income 2025 * | 364M 50.33M 4.2B | EV / Sales 2024 * | 2.55 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.93 x |
| P/E ratio 2024 * |
14.3
x | P/E ratio 2025 * |
11.2
x | Employees | 2,669 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.8% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.29% | ||
| 1 week | +2.78% | ||
| Current month | -11.05% | ||
| 1 month | -10.29% | ||
| 3 months | -18.23% | ||
| 6 months | -30.14% | ||
| Current year | -32.76% |
1 week
5.78
6.33
1 month
5.787.43
Current year
5.659.40
1 year
5.6511.19
3 years
5.6517.00
5 years
4.5621.50
10 years
3.2721.50
| Managers | Title | Age | Since |
|---|---|---|---|
Qiao Zhong Guan
FOU | Founder | 75 | 13/03/13 |
Qing Hui Li
DFI | Director of Finance/CFO | 59 | 01/14/01 |
Jian Yu Wang
COO | Chief Operating Officer | 63 | 01/03/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei XIong Huang
CHM | Chairman | 60 | 01/03/01 |
Qiao Zhong Guan
FOU | Founder | 75 | 13/03/13 |
Xiao Yan Yang
BRD | Director/Board Member | 61 | 01/03/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.09% | 12 M€ | -16.71% | - | |
| 0.00% | 34 M€ | +2.47% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 6.28 | +1.29% | 11 379 980 |
| 26/24/26 | 6.2 | +2.31% | 9,160,385 |
| 25/24/25 | 6.06 | +3.24% | 10,959,800 |
| 24/24/24 | 5.87 | -3.29% | 16,019,690 |
| 23/24/23 | 6.07 | +1.68% | 9,111,706 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Guangdong Hybribio Biotech Co Ltd is a company mainly engaged in production and sales of vitro diagnostic reagents. The Company operates two segments. The In Vitro Diagnostic Reagents and Supporting Equipment segment operates the research, development and production of nucleic acid detection reagents and supporting equipment, such as cervical cancer detection series products, deafness susceptibility gene detection series products and reproductive health management series products. The products are used in hospital clinical testing, large-scale population screening and other areas. The Medical Testing Service segment is involved in providing medical testing services for medical institutions, and the testing programs cover genetic metabolic diseases, infectious diseases, molecular pathological testing and tumor examinations.
Calendar
14/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.28
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.76% | 546M | |
| +1.69% | 12.8B | |
| -7.57% | 7.61B | |
| +3.22% | 5.41B | |
| +0.93% | 4.51B | |
| +8.87% | 4.49B | |
| +9.21% | 2.73B | |
| -13.87% | 2.02B | |
| -11.63% | 1.73B | |
| +0.31% | 1.64B |
- Stock Market
- Equities
- 300639 Stock
